Mesa Laboratories, Inc. - Common Stock (MLAB)

Investors aren't happy with Mesa Labs latest quarterly report.

Mesa Labs Q2 FY2026: A significant earnings beat with EPS of $1.76 overshadows a slight revenue miss. Mixed results for the life sciences tools company.

Mesa Labs (MLAB) reported Q1 fiscal 2026 earnings with revenue missing estimates at $59.54M but EPS soaring to $2.32, beating forecasts. Stock surged 36.4% pre-market.

Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.

MLAB stock results show that Mesa Laboratories beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.

The Nasdaq 100 closed higher by over 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million.

Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion.